반응 #2335

ord-468ebd3d0a054614b2598365cfd64b5d

반응 방정식

O=C(O)c1ccc(N2CCNCC2c2ccncc2)cc1
4-[(4-pyridyl)piperazin-1-yl]benzoic acid
On1nnc2ccccc21
HOBt
CN(C)C(On1nnc2ccccc21)=[N+](C)C.F[P-](F)(F)(F)(F)F
HBTU
CCN(C(C)C)C(C)C
diisopropylethylamine
CN(C)C=O
DMF
CCOC(=O)CN(C)C(=O)c1ccc(N2CCNCC2c2ccncc2)cc1
ethyl N-(4-[(4-pyridyl)piperazin-1-yl]benzoyl)-N-methylglycinate

용매

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타The ice-bath was removed
  2. 2
    workup.ADDITIONwas added
  3. 3
    workup.STIRRINGThe reaction mixture was stirred at room temperature under argon overnight
  4. 4
    workup.ADDITIONthen diluted with dichloromethane (30 ml) and water (30 ml)
  5. 5
    기타The organic layer was separated
  6. 6
    추출the aqueous layer was re-extracted with dichloromethane (30 ml)
  7. 7
    세척The combined organic extracts were washed with water, saturated sodium bicarbonate solution, water
  8. 8
    건조dried (MgSO4)
  9. 9
    기타evaporated
  10. 10
    여과The residue was purified by filtration through a short bed of activated (grade II) alumina by elution with ethyl acetate/methanol, 5:1

실험 절차

To a stirred mixture of 4-[(4-pyridyl)piperazin-1-yl]benzoic acid (prepared as in Example 30(i)) (311 mg), HOBt.H2O (170 mg) and HBTU (416 mg) in DMF (5 ml) at 0°-5° C. under argon was added diisopropylethylamine (0.75 ml). The ice-bath was removed and the reaction mixture was stirred at room temperature for 15 minutes before solid sarcosine, ethyl ester hydrochloride (154 mg) was added. The reaction mixture was stirred at room temperature under argon overnight then diluted with dichloromethane (30 ml) and water (30 ml). The organic layer was separated and the aqueous layer was re-extracted with dichloromethane (30 ml). The combined organic extracts were washed with water, saturated sodium bicarbonate solution, water, dried (MgSO4) and evaporated. The residue was purified by filtration through a short bed of activated (grade II) alumina by elution with ethyl acetate/methanol, 5:1, to give ethyl N-(4-[(4-pyridyl)piperazin-1-yl]benzoyl)-N-methylglycinate (92 mg) as an amorphous solid: NMR (d6 -DMSO+CD3CO2D) δ 1.18 (3H, t), 2.98 (3H, s), 3.44 (4H, m), 3.79 (4H, m), 4.11 (4H, m), 6.94 (2H, d), 7.12 (2H, d), 7.31 (2H, br, d), 8.19 (2H, d); m/Z 383 (M+H)+.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US05728701uspto-grants-1998_03